Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness

Hypertension Research

Volumn 26, Issue 9, 2003, Pages 677-683

  Tabara, Yasuharu ^a   Kohara, Katsuhiko ^a   Yamamoto, Yoshikuni ^a   Igase, Michiya ^a   Nakura, Jun ^a   Kondo, Ikuko ^a   Miki, Tetsuro ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Carotid atherosclerosis; Monocyte chemoattractant protein 1; Polymorphism

Indexed keywords

ADENINE; ANTIHYPERTENSIVE AGENT; GUANINE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ARTERY DIAMETER; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAROTID ARTERY DISEASE; COMMON CAROTID ARTERY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; IN VITRO STUDY; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

AGED; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CHEMOKINE CCL2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; TUNICA INTIMA; TUNICA MEDIA;

EID: 0141927472     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.26.677     Document Type: Article

References (41)

1. Schmidt AM, Stern DM: Chemokine on the rise: MCP-1 and restenosis. Arterioscler Thromb Vasc Biol 2001; 21: 297-299.
2. Rollins B: MCP-1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 1996; 5: 198-204.
3. Rollins B: Chemokines. Blood 1997; 90: 909-928.
4. Luster A: Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338: 436-445.
5. Landry DB, Couper LL, Bryant SR, Lindner V: Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury: induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1. Am J Pathol 1997; 151: 1085-1095.
6. Wysocki SJ, Zheng MH, Smith A, et al: Monocyte chemoattractant protein-1 gene expression in injured pig artery coincides with early appearance of infiltrating monocytes/macrophages. J Cell Biochem 1996; 62: 303-313.
7. Yla-Herttuala S, Lifton B, Rosenfeld M, et al: Expression of MCP-1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991; 88: 5252-5256.
8. Nelken N, Coughlin S, Gordon D, Wilcox J: MCP-1 in human atheromatous plaques. J Clin Invest 1991; 88: 1121-1127.
9. Yu X, Dluz S, Graves D, et al: Elevated expression of MCP-1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc Natl Acad Sci USA 1992; 89: 6953-6957.
10. Kowala M, Reece R, Beyer S, Gu C, Valentine M: Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE. Atherosclerosis 2000; 149: 323-330.
11. Matsumori A, Furukawa Y, Hashimoto T, et al: Plasma levels of monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol 1997; 29: 419-423.
12. Soejima H, Ogawa H, Yasue H, et al: Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction. J Am Coll Cardiol 1999; 34: 983-988.
13. Aukrust P, Berge RK, Ueland T, et al: Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes. J Am Coll Cardiol 2001; 37: 485-491.
14. van Aken BE, den Heijer M, Bus GM, van Deventer SJ, Reitsma PH: Recurrent venous thrombosis and markers of inflammation. Thromb Haemost 2000; 83: 536-539.
15. Jibiki T, Terai M, Shima M, et al: Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Japanese patients with Kawasaki disease. Arthritis Rheum 2001; 44: 2211-2212.
16. Ni W, Egashira K, Kataoka C, et al: New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice. Circulation 2001; 103: 2096-2101.
17. Stork S, Baumann K, von Schacky C, Angerer P: The effect of 17 beta-estradiol on MCP-1 serum levels in post-menopausal women. Cardiovasc Res 2002; 53: 642-649.
18. Rovin B, Lu L, Saxena R: A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999; 259: 344-348.
19. Szalai C, Duba J, Prohaszka Z, et al: Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD): coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 2001; 158: 233-239.
20. Aguilar F, Gonzalez-Escribano MF, Sanchez-Roman J, Nunez-Roldan A: MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus. Tissue Antigens 2001; 58: 335-338.
21. Yamamoto Y, Kohara K, Tabara Y, Miki T: Association between carotid arterial remodeling and plasma concentration of circulating hepatocyte growth factor. J Hypertens 2001; 19: 1975-1979.
22. Jiang YN, Kohara K, Hiwada K: Low wall shear stress in carotid arteries in subjects with left ventricular hypertrophy. Am J Hypertens 2000; 13: 892-898.
23. Kohara K, Jiang Y, Igase M, Hiwada K: Effect of reflection of arterial pressure on carotid circulation in essential hypertension. Am J Hypertens 1999; 12: 1015-1020.
24. O'Brien E, Mee F, Atkins N, Thomas M: Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175. Blood Press Monit 1996; 1: 55-61.
25. Uemura K, Nakura J, Kohara K, Miki T: Association of ACE I/D polymorphism with cardiovascular risk factors. Hum Genet 2000; 107: 239-242.
26. Cipollone F, Marini M, Fazia M, et al: Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 2001; 21: 327-334.
27. Kumar A, Ballantyne C, Michael L, et al: Induction of MCP-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation 1997; 95: 693-700.
28. Taubman M, Rollins B, Poon M, et al: JE mRNA accumulates rapidly in aortic injury and in PDGF-stimulated vascular smooth muscle cells. Circ Res 1992; 70: 314-325.
29. Oshima S, Ogawa H, Hokimoto S, et al: Plasma monocyte chemoattractant protein-1 antigen levels and the risk of restenosis after coronary stent implantation. Jpn Circ J 2001; 65: 261-264.
30. Olsen F: The secondary and tertiary inflammatory cellular reaction in arterioles damaged by acute angiotensin-hypertension in rats. Acta Pathol Microbiol Scand A 1970; 78: 451-457.
31. Luft FC, Mervaala E, Muller DN, et al: Hypertension-induced end-organ damage: a new transgenic approach to an old problem. Hypertension 1999; 33: 212-218.
32. Tabara Y, Kohara K, Nakura J, Miki T: Risk factor-gene interaction in carotid atherosclerosis: effect of gene polymorphisms of renin-angiotensin system. J Hum Genet 2001; 46: 278-284.
33. Kohara K, Tabara Y, Yamamoto Y, Miki T: Orthostatic hypertension: another orthostatic disorder to be aware of. J Am Geriatr Soc 2000; 48: 1538-1539.
34. Kohara K, Tabara Y, Yamamoto Y, Igase M, Nakura J, Miki T: Genotype-specific association between circulating soluble cellular adhesion molecules and carotid intimamedia thickness in community residents: J-SHIPP study: Shimanami Health Promoting Program. Hypertens Res 2002; 25: 31-39.
35. Yamamoto Y, Kohara K, Tabara Y, Igase M, Nakura J, Miki T: Plasma hepatocyte growth factor and the relationship between risk factors and carotid atherosclerosis. Hypertens Res 2002; 25: 661-667.
36. Kohara K, Tabara Y, Yamamoto Y, Igase M, Miki T: Chlamydia pneumoniae seropositivity is associated with increased plasma levels of soluble cellular adhesion molecules in community-dwelling subjects: the Shimanami Health Promoting Program (J-SHIPP) study. Stroke 2002; 33: 1474-1479.
37. Rossi A, Baldo-Enzi G, Calabro A, Sacchetto A, Pessina AC, Rossi GP: The renin-angiotensin-aldosterone system and carotid artery disease in mild-to-moderate primary hypertension. J Hypertens 2000; 18: 1401-1409.
38. Kawamoto R, Kohara K, Tabara Y, Miki T: An interaction between systolic blood pressure and angiotensin-converting enzyme gene polymorphism on carotid atherosclerosis. Hypertens Res 2002; 25: 875-880.
39. Gerli R, Monti D, Bistoni O, et al: Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenarians. Mech Ageing Dev 2000; 121: 37-46.
40. Inadera H, Egashira K, Takemoto M, Ouchi Y, Matsushima K: Increase in circulating levels of monocyte chemoattractant protein-1 with aging. J Interferon Cytokine Res 1999; 19: 1179-1182.
41. Hwang SY, Cho ML, Park B, et al: Allelic frequency of the MCP-1 promoter - 2518 polymorphism in the Korean population and in Korean patients with rheumatoid arthritis, systemic lupus erythematosus and adult-onset Still's disease. Eur J Immunogenet 2002; 29: 413-416.